非塩ビ点滴バッグ市場規模、シェア、成長分析、製品別、素材別、内容物別、地域別 - 産業別予測、2024～2031年

非塩ビ点滴バッグの世界市場規模は、2022年に16億7,000万米ドルと評価され、2023年の18億5,000万米ドルから2031年には42億4,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは10.9％で成長する見通しです。

非塩ビ点滴バッグ市場は、特に手術室や腫瘍科での取り扱いや輸送における固有の安全性と実用性によって、大きな成長が見込まれています。有害な化合物を溶出させる可能性のある従来のPVC製輸液バッグに関連する汚染防止とリスクの最小化にますます焦点が当てられる中、ポリプロピレンやEVAなどの非塩ビ代替品が人気を集めています。これらのバッグは薬剤の完全性を守るだけでなく、廃棄も簡単です。非経口栄養や化学療法における主な用途は、ヘルスケアにおけるその重要な役割を浮き彫りにしています。様々な革新的素材が登場するにつれて、非塩ビ点滴バッグの需要は、PVC包装からの幅広いシフトを反映し、複数の医療用途におけるその価値を強化しながら、上昇すると予想されます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術の進歩
• 規制情勢

非塩ビ点滴バッグ市場規模：製品別

• 市場概要
• シングルチャンバー
• マルチチャンバー

非塩ビ点滴バッグ市場規模：素材別

• 市場概要
• エチレン酢酸ビニル
• ポリプロピレン
• コポリエステルエーテル
• その他

非塩ビ点滴バッグ市場規模：内容物別

• 市場概要
• 冷凍ミックス
• 液体混合物

非塩ビ点滴バッグ市場規模：地域別

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021-2023）

主要企業プロファイル

• Baxter
• B. Braun Melsungen AG
• Pfizer, Inc.（Hospira）
• Fresenius Kabi AG
• JW Life Science
• RENOLIT
• PolyCine GmbH
• Sealed Air
• ANGIPLAST PVT. LTD
• Shanghai Solve Care Co Ltd.
• Kraton Corporation
• Jiangxi Sanxin Medtec Co., Ltd.
• Otsuka Pharmaceutical Co., Ltd
• Fresenius Kabi AG
• PolyCine GmbH

結論と推奨事項

Global Non-PVC IV Bags Market size was valued at USD 1.67 billion in 2022 and is poised to grow from USD 1.85 billion in 2023 to USD 4.24 billion by 2031, growing at a CAGR of 10.9% during the forecast period (2024-2031).

The market for non-PVC IV bags is poised for significant growth, driven by their inherent safety and practicality for handling and transport, especially in operating rooms and oncology departments. With an increased focus on contamination prevention and minimizing risks associated with traditional PVC IV bags, which can leach harmful compounds, non-PVC alternatives like polypropylene and EVA are gaining traction. These bags not only safeguard drug integrity but are also easy to dispose of. Their primary applications in parenteral feeding and chemotherapy highlight their essential role in healthcare. As various innovative materials emerge, the demand for non-PVC IV bags is expected to rise, reflecting a broader shift away from PVC packaging and reinforcing their value across multiple medical applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Non-Pvc Iv Bags market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Non-Pvc Iv Bags Market Segmental Analysis

Global Non-PVC IV Bags Market is segmented by product, material, content and region. Based on product, the market is segmented into single chamber and multi chamber. Based on material, the market is segmented into ethylene vinyle acetate, polypropylene, copolyester ether and others. Based on content, the market is segmented into frozen mixture and liquid mixture. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Non-Pvc Iv Bags Market

The Global Non-PVC IV Bags market is poised for significant growth driven mainly by the increasing incidence of cancer, which necessitates both oral and intravenous drug administration. As reported by the World Health Organization (WHO), cancer is the second leading cause of mortality globally, propelling demand for effective treatment options. Additionally, the surge in patient numbers across healthcare facilities has further contributed to market expansion. This growth is also influenced by the rising need for error prevention in drug delivery, enhanced demand for advanced IV storage solutions, and stringent regulations aimed at minimizing hospital-acquired infections. Collectively, these factors are amplifying the appeal of non-PVC IV bags, especially for oncology treatments like chemotherapy and targeted therapies.

Restraints in the Global Non-Pvc Iv Bags Market

The growth of the Global Non-PVC IV Bags market could be impeded by concerns regarding phthalates leaching from medical equipment, posing risks to individuals and the environment. These apprehensions may present significant challenges for the non-PVC IV bags sector throughout the projected period. Additionally, stringent regulations governing the use and disposal of PVC are expected to create further obstacles, affecting market expansion. As a result, manufacturers and stakeholders in the non-PVC IV bags market must navigate these restrictions carefully to mitigate risks and align with evolving regulations, which could influence their operational strategies moving forward.

Market Trends of the Global Non-Pvc Iv Bags Market

The Global Non-PVC IV Bags market is poised for significant growth in the coming years, driven by the rising adoption of ethylene vinyl acetate (EVA) in blood banks and the expansion of facilities for storing blood and blood components. As awareness of the importance of safe blood storage increases, so does the demand for reliable packaging solutions. Additionally, the market for copolyester ether is expected to thrive, attributed to its unique advantages such as chemical resistance, superior durability, and clarity. These factors collectively point toward a growing trend in non-PVC IV bag usage, paralleling the global expansion of blood banks and healthcare infrastructure.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape

Global Non-Pvc Iv Bags Market Size by Product & CAGR (2024-2031)

• Market Overview
• Single Chamber
• Multi Chamber

Global Non-Pvc Iv Bags Market Size by Material & CAGR (2024-2031)

• Market Overview
• Ethylene Vinyle Acetate
• Polypropylene
• Copolyester Ether
• Others

Global Non-Pvc Iv Bags Market Size by Content & CAGR (2024-2031)

• Market Overview
• Frozen Mixture
• Liquid Mixture

Global Non-Pvc Iv Bags Market Size & CAGR (2024-2031)

• North America (Product, Material, Content)
  • USA
  • Canada
• Europe (Product, Material, Content)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Material, Content)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Material, Content)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Material, Content)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Baxter
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer, Inc. (Hospira)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JW Life Science
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RENOLIT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PolyCine GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sealed Air
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ANGIPLAST PVT. LTD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai Solve Care Co Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kraton Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangxi Sanxin Medtec Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Pharmaceutical Co., Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PolyCine GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation